Fisher & Paykel Healthcare Corporation Limited

FSPKFOTCHealthcare● Active

$22.52

+$0.00(+0.00%)

Market Cap$13.2B

P/E Ratio—

52W High$25.69

52W Low$16.35

Avg Volume311

Open$22.52

Beta0.89

Free Cash Flow Financials Revenue

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

FSPKF · free cash flow · updated Jun 13, 2026

Core FCF metrics

FSPKF · FCF · TTM · margin & CAGR

Free cash flow was $495.3M for FY2026 (fiscal year ending 2026-03-31), up 11.2% year-over-year The FCF margin was 21.0%. Five-year CAGR stands at +2.4%.

FY2026 Free Cash Flow$495.3M▲ +11.2% YoY

Trailing 12M (TTM)$1.13Btrailing 4 quarters sum

FCF Margin21.0%$495.3M ÷ revenue

3-Year CAGR+164.1%FY2023 → FY2026

5-Year CAGR+2.4%FY2021 → FY2026

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 13, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

FSPKF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2026Latest$669.8M(175M)$495.3M▲ +11.2%21.0%

FY2025$548.6M(103M)$445.6M▲ +391.8%34.8%

FY2024$429.6M(339M)$90.6M▲ +236.8%5.2%

FY2023$238.2M(211M)$26.9M▼ 82.6%1.7%

FY2022$324.3M(170M)$154.5M▼ 64.9%9.4%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

FSPKF · P/FCF · FCF yield · FCF per share

Fisher & Paykel Healthcare Corporation Limited (FSPKF) trades at a FCF yield of 2.12% and a price-to-free-cash-flow ratio of 11.7x. FCF per share stands at $1.93, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

2.12%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.93

TTM FCF ÷ Shares Outstanding

Price / FCF

x11.7

Share Price ÷ FCF per Share

EV / FCF (TTM)

x46.6

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-03-31

Cash flow statement summary

FSPKF · cash flow statement · operating / investing / financing

For FY2026, Fisher & Paykel Healthcare Corporation Limited generated $669.8M in operating cash flow and spent 175M in capital expenditures, yielding $495.3M in free cash flow.

Operating Activities

+$669.8M

Cash from core business operations

2026-03-31

Investing Activities

−$197.2M

CapEx, acquisitions & investments

2026-03-31

Financing Activities

−$279.5M

Buybacks, dividends & debt

2026-03-31

FCF FormulaOperating CF ($669.8M) − |CapEx| (175M) = FCF ($495.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

FSPKF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Fisher & Paykel Healthcare Corporation LimitedYOU

FSPKF

$495.3M+11.2%21.0%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Fisher & Paykel Healthcare Corporation Limited (FSPKF) reported free cash flow of $495.3M for FY2026 (fiscal year ending 2026-03-31), up 11.2% year-over-year. The FCF margin was 21.0%.

Based on available data, Fisher & Paykel Healthcare Corporation Limited has maintained positive free cash flow for at least 14 fiscal year(s). FCF peaked at $495.3M in FY2026. The 5-year CAGR stands at +2.4%.

Fisher & Paykel Healthcare Corporation Limited's FCF yield is 2.12% and price-to-FCF ratio is 11.7x for FY2026, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

FSPKF free cash flow · 8 questions

Fisher & Paykel Healthcare Corporation Limited free cash flow was $495.3M for FY2026, up 11.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.13B.

FSPKF free cash flowFSPKF FCFFSPKF FCF 2026FSPKF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Fisher & Paykel Healthcare Corporation Limited · Fisher & Paykel Healthcare Corporation Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 13, 2026